Michael R. Mcalevey serves as Executive at HCA Healthcare, Inc., where they oversee executive responsibilities. Since joining the company, Michael R. Mcalevey has executed 9 insider transactions totaling $2.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 29, 2026 involved receiving (via award) 8,067 shares valued at $0.
Michael R. Mcalevey currently holds 8,067 shares of HCA Healthcare, Inc. (HCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael R. Mcalevey has been a net seller of HCA stock. They have purchased $242.6K and sold $1.8M worth of shares.
Michael R. Mcalevey's most recent insider trade was on Jan 29, 2026, when they sold 8,067 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $473.79 |
| Discretionary |
| Nov 3, 2025 | HCA | $4.3M | Payment | 9,278 | $461.56 | Discretionary |
| Nov 3, 2025 | HCA | $3.1M | Option Exercise | 13,170 | $236.61 | Discretionary |
| Jan 28, 2024 | HCA | $0 | Option Exercise | 1,940 | $N/A | Discretionary |
| Jan 28, 2024 | HCA | $138.6K | Payment | 489 | $283.43 | Discretionary |
| Jan 28, 2023 | HCA | $0 | Option Exercise | 1,940 | $N/A | Discretionary |
| Jan 28, 2023 | HCA | $124.6K | Payment | 489 | $254.77 | Discretionary |
| Apr 29, 2022 | HCA | $242.6K | Purchase | 1,110 | $218.56 | Discretionary |